Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
10 studies found for:    viaskin
Show Display Options
Rank Status Study
1 Active, not recruiting Milk Patch for Eosinophilic Esophagitis
Conditions: Eosinophilic Esophagitis;   Milk Allergy
Interventions: Drug: Viaskin Milk 500 mcg;   Drug: Viaskin Placebo
2 Active, not recruiting Viaskin Pertussis Vaccine Trial
Condition: Whooping Cough
Interventions: Biological: Viaskin PT 25 mcg;   Biological: Viaskin PT 50 mcg;   Biological: Viaskin PT Placebo;   Biological: Boostrix™
3 Completed Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children
Condition: Peanut Allergy
Intervention: Biological: Viaskin Peanut 250 mcg
4 Enrolling by invitation Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
Condition: Peanut Allergy
Intervention: Drug: Viaskin Peanut 250µg
5 Active, not recruiting Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
Condition: Peanut Allergy
Interventions: Biological: Viaskin Peanut 250mcg;   Biological: Placebo
6 Active, not recruiting Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy
Condition: Food Allergy
Interventions: Biological: Viaskin Milk 150 mcg;   Biological: Viaskin Milk 300 mcg;   Biological: Viaskin Milk 500 mcg;   Biological: Viaskin Placebo
7 Completed Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Condition: Peanut Allergy
Interventions: Biological: Viaskin Peanut 50 mcg;   Biological: Viaskin Peanut 100 mcg;   Biological: Viaskin Peanut 250 mcg;   Biological: Viaskin Placebo
8 Active, not recruiting Safety Study of Viaskin Peanut to Treat Peanut Allergy
Condition: Peanut Allergy
Interventions: Biological: Viaskin Peanut 250 mcg;   Biological: Placebo
9 Completed Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Condition: Peanut Allergy
Interventions: Biological: Whole peanut extract;   Biological: Placebo formulation
10 Active, not recruiting
Has Results
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Conditions: Peanut Hypersensitivity;   Food Hypersensitivity;   Hypersensitivity;   Hypersensitivity, Immediate
Interventions: Biological: Placebo Viaskin® Patch;   Biological: Low-dose DBV712 Viaskin® Patch;   Biological: High-dose DBV712 Viaskin® Patch

Study has passed its completion date and status has not been verified in more than two years.